A Primary Care Multilevel mHealth Colorectal Cancer Screening (mCRC) Intervention
初级保健多层次 mHealth 结直肠癌筛查 (mCRC) 干预
基本信息
- 批准号:8562335
- 负责人:
- 金额:$ 32.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAdultAmericanAppointmentAttentionAttitudeAwarenessBehaviorBeliefCaringCellular PhoneClinicCognitiveCommunitiesComputer softwareDecision AidDevelopmentDevicesEnrollmentEnvironmentEquipmentEventExplosionFailureFutureHabitsHealth PersonnelIntentionInterventionLife StyleMeasuresMediatingMediator of activation proteinMedicalModelingMultimediaOutcomeParticipantPatient CarePatient EducationPatientsPersonsPhysiciansPopulation HeterogeneityPrimary Health CareProcessProtocols documentationProviderPublic HealthRandomizedRandomized Controlled TrialsResearchScheduleSelf EfficacyServicesSystemTabletsTechnologyTestingTextTimeUnited StatesVisitagedbasecolorectal cancer screeningcostcost effectivedesignempoweredexperiencefollow-uphealth literacyimprovedinnovationintervention effectliteracymortalitynovelprogramspublic health relevancerandomized trialscreeningsocialsocioeconomicstouchscreentreatment as usualuser-friendly
项目摘要
DESCRIPTION (provided by applicant): Colorectal cancer (CRC) screening saves lives yet remains underutilized in the United States, with approximately 1 in 3 eligible Americans remaining unscreened. Prior research has documented numerous barriers to CRC screening, including patient factors (i.e., lack of awareness of screening options, negative attitudes and beliefs, low health literacy) and provider/system factors (i.e., lack of physician time, scheduling
barriers, absence of after-visit patient support). Prior attempts to increase CRC screening have generally targeted either patient or provider/system barriers, with only modest results. To achieve the highest screening rates possible, a multilevel intervention that is time-efficient, easily implemented, and appropriate for varying literacy levels is urgently needed. The increasing popularity of user-friendly mobile devices makes mHealth, or the use of mobile technology to enhance patient care, an attractive option. We have designed an innovative low cost intervention to increase the receipt of CRC screening by leveraging mobile technology to inform, activate, and support patients before, during, and after their primary care visits. Our intervention can be easily disseminated and implemented in primary care practices and is appropriate for patients of all literacy levels. This project will evaluate the efficacy of our innovative multilevel mHealth CRC screening intervention (mCRC). The conceptual framework for the mCRC system is based on the social cognitive model emphasizing reciprocal determinism, or the dynamic interaction of the person, the behavior, and the environment. The mCRC system includes: 1) a tablet CRC screening decision aid that will collect patient information, deliver a screening message, and allow patients to make a screening decision; 2) "self-service" protocols that empower staff to order patient-requested screening tests; and 3) post-decision follow-up support for patients via automated and interactive text messaging. We will test the mCRC system in a randomized controlled trial conducted in community-based primary care practices serving a racially and socioeconomically diverse population. Patients will be randomized to either the mCRC system or a tablet educational program about healthy lifestyle habits. The trial will evaluate: 1) the ability of the mCRC system to increase receipt of
CRC screening within 24 weeks as confirmed by medical chart reviews; 2) the potential mechanisms of change by which the mCRC system facilitates screening (i.e., patient ability to form a screening decision, patient attitudes and beliefs, patient self-efficacy, patient intention,
and the occurrence of patient-provider CRC screening discussions); and 3) the additional cost of the mCRC system per patient screened, focusing on the system costs of staff time and technology. At the completion of our study, we will make the mCRC system freely available to help increase CRC screening and improve public health.
描述(由申请人提供):结直肠癌(CRC)筛查可以挽救生命,但在美国仍然没有得到充分利用,大约三分之一的合格美国人仍然没有接受筛查。先前的研究已经记录了CRC筛查的许多障碍,包括患者因素(即,缺乏对筛查选择的认识,消极的态度和信念,低健康素养)和提供者/系统因素(即,医生时间不足,日程安排
障碍,缺乏访视后患者支持)。先前增加CRC筛查的尝试通常针对患者或提供者/系统障碍,结果有限。为了实现尽可能高的筛查率,迫切需要一种多层次的干预措施,这种干预措施具有时间效率,易于实施,适合不同的识字水平。用户友好型移动的设备的日益普及使得移动健康或使用移动的技术来增强患者护理成为一个有吸引力的选择。我们设计了一种创新的低成本干预措施,通过利用移动的技术在初级保健就诊之前、期间和之后通知、激活和支持患者,来增加CRC筛查的接受率。我们的干预措施可以很容易地传播和实施在初级保健的做法,是适合所有识字水平的患者。该项目将评估我们创新的多层次mHealth CRC筛查干预(mCRC)的有效性。mCRC系统的概念框架是基于社会认知模型,强调互惠决定论,或人,行为和环境的动态相互作用。mCRC系统包括:1)平板电脑CRC筛查决策辅助,其将收集患者信息,传递筛查消息,并允许患者做出筛查决定; 2)“自助”协议,其授权工作人员订购患者请求的筛查测试;以及3)通过自动化和交互式文本消息为患者提供决策后随访支持。我们将在一项随机对照试验中测试mCRC系统,该试验在为种族和社会经济多样化人群服务的社区初级保健实践中进行。患者将被随机分配至mCRC系统或关于健康生活习惯的平板电脑教育计划。本试验将评价:1)mCRC系统增加接受
经病历审查确认的24周内的CRC筛查; 2)mCRC系统促进筛查的潜在变化机制(即,患者形成筛查决策的能力、患者态度和信念、患者自我效能、患者意图,
以及患者-提供者CRC筛查讨论的发生);以及3)每名接受筛查的患者的mCRC系统的额外成本,重点是员工时间和技术的系统成本。在我们的研究完成后,我们将免费提供mCRC系统,以帮助增加CRC筛查和改善公共卫生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David P Miller其他文献
Color Doppler and two-dimensional echocardiographic determination of the mechanism of aortic regurgitation with surgical correlation.
彩色多普勒和二维超声心动图测定主动脉瓣关闭不全的机制与手术的相关性。
- DOI:
- 发表时间:
1996 - 期刊:
- 影响因子:6.5
- 作者:
G. Cohen;Carol I. Duffy;Allan L. Klein;David P Miller;D. Cosgrove;W. Stewart - 通讯作者:
W. Stewart
Long‐Term Protection from Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade with Percutaneous Coronary Intervention
经皮冠状动脉介入治疗短暂整合素 β3 阻断的随机试验对心肌缺血事件的长期保护
- DOI:
10.1097/00132586-199808000-00009 - 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
E. Topol;J. Ferguson;H. Weisman;J. Tcheng;S. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf - 通讯作者:
R. Califf
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block
阿昔单抗对血管成形术并发症的减少很大程度上与基线病变形态无关。
- DOI:
10.1016/s0735-1097(98)00403-3 - 发表时间:
1998 - 期刊:
- 影响因子:24
- 作者:
Stephen G. Ellis;A. Lincoff;David P Miller;J. Tcheng;N. Kleiman;D. Kereiakes;R. Califf;E. Topol - 通讯作者:
E. Topol
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
早期持续再灌注对既往心肌梗塞患者的益处(GUSTO-I 试验)。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:2.8
- 作者:
D. Brieger;K. Mak;H. White;N. Kleiman;David P Miller;A. Vahanian;A. Ross;R. Califf;E. Topol - 通讯作者:
E. Topol
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.
在一项短期整合素 β3 阻断联合经皮冠状动脉介入治疗的随机试验中,可长期预防心肌缺血事件。
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
E. Topol;J. Ferguson;H. Weisman;J. Tcheng;Stephen G. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf - 通讯作者:
R. Califf
David P Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David P Miller', 18)}}的其他基金
A cloud-based digital health navigation program for colorectal cancer screening
基于云的结直肠癌筛查数字健康导航程序
- 批准号:
10697474 - 财政年份:2023
- 资助金额:
$ 32.59万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
10165873 - 财政年份:2020
- 资助金额:
$ 32.59万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
10551856 - 财政年份:2020
- 资助金额:
$ 32.59万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
10318171 - 财政年份:2020
- 资助金额:
$ 32.59万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
10062917 - 财政年份:2020
- 资助金额:
$ 32.59万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
9885242 - 财政年份:2020
- 资助金额:
$ 32.59万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
9895633 - 财政年份:2018
- 资助金额:
$ 32.59万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
10116309 - 财政年份:2018
- 资助金额:
$ 32.59万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
10382400 - 财政年份:2018
- 资助金额:
$ 32.59万 - 项目类别:
相似海外基金
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
A neuroimaging approach to advance mechanistic understanding of tobacco use escalation risk among young adult African American vapers
一种神经影像学方法,可促进对年轻非洲裔美国电子烟使用者烟草使用升级风险的机制理解
- 批准号:
10509308 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
Understanding social undermining of weight management behaviors in young adult African American women
了解年轻非洲裔美国女性体重管理行为的社会破坏
- 批准号:
10680412 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
Understanding social undermining of weight management behaviors in young adult African American women
了解年轻非洲裔美国女性体重管理行为的社会破坏
- 批准号:
10535890 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
A neuroimaging approach to advance mechanistic understanding of tobacco use escalation risk among young adult African American vapers
一种神经影像学方法,可促进对年轻非洲裔美国电子烟使用者烟草使用升级风险的机制理解
- 批准号:
10629374 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
Impact of Adult Day Services on Psychosocial and Physiological Measures of Stress among African American Dementia Family Caregivers
成人日间服务对非裔美国痴呆症家庭护理人员的社会心理和生理压力测量的影响
- 批准号:
10553725 - 财政年份:2021
- 资助金额:
$ 32.59万 - 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
- 批准号:
10494191 - 财政年份:2021
- 资助金额:
$ 32.59万 - 项目类别:
Impact of Adult Day Services on Psychosocial and Physiological Measures of Stress among African American Dementia Family Caregivers
成人日间服务对非裔美国痴呆症家庭护理人员的社会心理和生理压力测量的影响
- 批准号:
10328955 - 财政年份:2021
- 资助金额:
$ 32.59万 - 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
- 批准号:
10437374 - 财政年份:2021
- 资助金额:
$ 32.59万 - 项目类别: